Alkem Laboratories Ltd banner

Alkem Laboratories Ltd
NSE:ALKEM

Watchlist Manager
Alkem Laboratories Ltd Logo
Alkem Laboratories Ltd
NSE:ALKEM
Watchlist
Price: 5 574.5 INR 1.44%
Market Cap: ₹666.5B

Relative Value

The Relative Value of one ALKEM stock under the Base Case scenario is hidden INR. Compared to the current market price of 5 574.5 INR, Alkem Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALKEM Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ALKEM Competitors Multiples
Alkem Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Alkem Laboratories Ltd
NSE:ALKEM
660.3B INR 4.7 28.1 21.7 25
US
Eli Lilly and Co
NYSE:LLY
987B USD 15.1 47.8 32.2 34.3
US
Johnson & Johnson
NYSE:JNJ
592.7B USD 6.3 22.1 15.3 18.9
CH
Roche Holding AG
SIX:ROG
298.4B CHF 4.8 31.5 13.3 15.5
UK
AstraZeneca PLC
LSE:AZN
237.8B GBP 5.5 31.7 17.4 24.6
CH
Novartis AG
SIX:NOVN
248.3B CHF 5.6 22.7 14 18
US
Merck & Co Inc
NYSE:MRK
309B USD 4.8 16.9 10.6 12.4
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.4 10.4 7.7 9.1
US
Pfizer Inc
NYSE:PFE
154.4B USD 2.5 19.9 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
124.1B USD 2.6 17.6 7.4 9.1
P/E Multiple
Earnings Growth PEG
IN
Alkem Laboratories Ltd
NSE:ALKEM
Average P/E: 24.9
28.1
8%
3.5
US
Eli Lilly and Co
NYSE:LLY
47.8
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22.1
7%
3.2
CH
Roche Holding AG
SIX:ROG
31.5
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.7
26%
1.2
CH
Novartis AG
SIX:NOVN
22.7
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.9
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.4
7%
1.5
US
Pfizer Inc
NYSE:PFE
19.9
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.6
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Alkem Laboratories Ltd
NSE:ALKEM
Average EV/EBITDA: 43.6
21.7
15%
1.4
US
Eli Lilly and Co
NYSE:LLY
32.2
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.3
2%
7.7
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
17.4
11%
1.6
CH
Novartis AG
SIX:NOVN
14
9%
1.6
US
Merck & Co Inc
NYSE:MRK
10.6
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.7
7%
1.1
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.4
-12%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett